Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
02:32
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

BSH 2020 VIRTUAL

 

9-14 November 2020 Virtual Conference
FAQs
   
Discussion forum - BSH 2020 VIRTUAL
    Topic - Thrombosis and Haemostasis

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 166
Visits: 34
Title: Investigation of von Willebrand factor polymorphisms in congenital Thrombotic Thrombocytopenic Purpura
Authors: Chiara Lupo , Chiara Lupo: Haemostasis Research Unit, University College London, London, UKChiara Vendramin: Haemostasis Research Unit, University College London, London, UKFerras Alwan: Department of Haematology, University College London Hospitals, London, UKMarie Scully: Haemostasis Research Unit, University College London & Department of Haematology, University College London Hospitals, London, UK
Centre: 

You must be registered to reply or comment.

INVESTIGATION OF VON WILLEBRAND FACTOR POLYMORPHISMS IN CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA

Chiara Lupo
Thread initiator
Subspeciality
Reg: 11/3/2020

Comment# 1

I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 11/9/2020 12:01:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 1
Visits: 536
Title: Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial
Authors: Daniel Leongamornlert , E. Barretta, S. Lee, T. Creasey, R. Mitchell, A. A. Kirkwood, L Clifton-Hadley, P. Patrick, P. Campbell, B. Patel, A. Moorman, A. K. Fielding, E. Papaemmanuil
Centre: 

Poster most viewed in this topic
Poster: 161
Visits: 82
Title: Bone And Joint Health Markers In Persons With Haemophilia A (PwHA) Treated With Emicizumab In HAVEN 3
Authors: Anna Kiialainen , Anna Kiialainen:Oncology Biomarker Development,F. Hoffmann-La Roche Ltd,Basel,Switzerland|Markus Niggli:Statistics,F. Hoffmann-La Roche Ltd,Basel,Switzerland|Christine Kempton:Hematology and Medical O
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert